BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37396159)

  • 1. Costunolide alleviated DDC induced ductular reaction and inflammatory response in murine model of cholestatic liver disease.
    Hao J; Shen X; Lu K; Xu Y; Chen Y; Liu J; Shao X; Zhu C; Ding Y; Xie X; Wu J; Yang Q
    J Tradit Complement Med; 2023 Jul; 13(4):345-357. PubMed ID: 37396159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gentiopicroside Ameliorated Ductular Reaction and Inflammatory Response in DDC-induced Murine Cholangiopathies Model.
    Hao J; Wu J; Yang Q; Lu K; Xu Y; Chen Y; Liu J; Shao X; Zhu C; Ding Y; Xie X
    Curr Mol Pharmacol; 2023 Oct; ():. PubMed ID: 37881074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal obesogenic diet enhances cholestatic liver disease in offspring.
    Thompson MD; Hinrichs H; Faerber A; Tarr PI; Davidson NO
    J Lipid Res; 2022 May; 63(5):100205. PubMed ID: 35341737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of herbal medicine Huangqi decoction against chronic cholestatic liver injury by inhibiting bile acid-stimulated inflammation in DDC-induced mice.
    Li WK; Wang GF; Wang TM; Li YY; Li YF; Lu XY; Wang YH; Zhang H; Liu P; Wu JS; Ma YM
    Phytomedicine; 2019 Sep; 62():152948. PubMed ID: 31129431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of EGFR catalytic activity in hepatocytes improves liver regeneration following DDC-induced cholestatic injury by promoting a pro-restorative inflammatory response.
    Lazcanoiturburu N; García-Sáez J; González-Corralejo C; Roncero C; Sanz J; Martín-Rodríguez C; Valdecantos MP; Martínez-Palacián A; Almalé L; Bragado P; Calero-Pérez S; Fernández A; García-Bravo M; Guerra C; Montoliu L; Segovia JC; Valverde ÁM; Fabregat I; Herrera B; Sánchez A
    J Pathol; 2022 Nov; 258(3):312-324. PubMed ID: 36148647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin improves cholestatic liver disease via the gut-liver axis.
    Liu X; Li J; Shi M; Fu J; Wang Y; Kang W; Liu J; Zhu F; Huang K; Chen X; Liu Y
    J Pineal Res; 2024 Jan; 76(1):e12929. PubMed ID: 38047407
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Zhang L; Hu Y; Qi S; Zhang C; Zhou Q; Zhang D; Mu Y; Zhang H; Chen G; Liu P; Chen J; Liu W
    Front Pharmacol; 2022; 13():965914. PubMed ID: 36339578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian Target of Rapamycin Complex 2 Signaling Is Required for Liver Regeneration in a Cholestatic Liver Injury Murine Model.
    Zhou Y; Xu M; Liu P; Liang B; Qian M; Wang H; Song X; Nyshadham P; Che L; Calvisi DF; Li F; Lin S; Chen X
    Am J Pathol; 2020 Jul; 190(7):1414-1426. PubMed ID: 32275903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic preconditioning protects BSEP/ABCB11
    Fuchs CD; Paumgartner G; Wahlström A; Schwabl P; Reiberger T; Leditznig N; Stojakovic T; Rohr-Udilova N; Chiba P; Marschall HU; Trauner M
    J Hepatol; 2017 Jan; 66(1):95-101. PubMed ID: 27593105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Melittin Treatment in Cholangitis and Biliary Fibrosis in a Model of Xenobiotic-Induced Cholestasis in Mice.
    Kim KH; Sung HJ; Lee WR; An HJ; Kim JY; Pak SC; Han SM; Park KK
    Toxins (Basel); 2015 Aug; 7(9):3372-87. PubMed ID: 26308055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of CBP/β-catenin signaling ameliorated fibrosis in cholestatic liver disease.
    Kimura M; Nishikawa K; Osawa Y; Imamura J; Yamaji K; Harada K; Yatsuhashi H; Murata K; Miura K; Tanaka A; Kanto T; Kohara M; Kamisawa T; Kimura K
    Hepatol Commun; 2022 Oct; 6(10):2732-2747. PubMed ID: 35855613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired bile acid handling and aggravated liver injury in mice expressing a hepatocyte-specific RXRα variant lacking the DNA-binding domain.
    Kosters A; Felix JC; Desai MS; Karpen SJ
    J Hepatol; 2014 Feb; 60(2):362-9. PubMed ID: 24120911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of keratin 19 favours the development of cholestatic liver disease through decreased ductular reaction.
    Chen Y; Guldiken N; Spurny M; Mohammed HH; Haybaeck J; Pollheimer MJ; Fickert P; Gassler N; Jeon MK; Trautwein C; Strnad P
    J Pathol; 2015 Nov; 237(3):343-54. PubMed ID: 26108453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3,5-Diethoxycarbonyl-1,4-Dihydrocollidine Diet: A Rodent Model in Cholestasis Research.
    Pose E; Sancho-Bru P; Coll M
    Methods Mol Biol; 2019; 1981():249-257. PubMed ID: 31016659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear Translocation of RELB Is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice.
    Elßner C; Goeppert B; Longerich T; Scherr AL; Stindt J; Nanduri LK; Rupp C; Kather JN; Schmitt N; Kautz N; Breuhahn K; Ismail L; Heide D; Hetzer J; García-Beccaria M; Hövelmeyer N; Waisman A; Urbanik T; Mueller S; Gdynia G; Banales JM; Roessler S; Schirmacher P; Jäger D; Schölch S; Keitel V; Heikenwalder M; Schulze-Bergkamen H; Köhler BC
    Gastroenterology; 2019 Mar; 156(4):1190-1205.e14. PubMed ID: 30445013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CsHscB Derived from a Liver Fluke
    Yu Q; Koda S; Xu N; Li J; Wang JL; Liu M; Liu JX; Zhang Y; Yang HM; Zhang BB; Li XY; Li XC; Tang RX; Zheng KY; Yan C
    Curr Mol Med; 2024; 24(4):505-515. PubMed ID: 37076961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin attenuates cholestatic liver injury via inhibition of the inflammatory response.
    Tan Y; Zhao N; Xie Q; Xu Z; Chai J; Zhang X; Li Y
    Mol Cell Biochem; 2023 Nov; 478(11):2527-2537. PubMed ID: 36869985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch signaling promotes ductular reactions in biliary atresia.
    Zagory JA; Dietz W; Park A; Fenlon M; Xu J; Utley S; Mavila N; Wang KS
    J Surg Res; 2017 Jul; 215():250-256. PubMed ID: 28688656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic protein 9 as a key regulator of liver progenitor cells in DDC-induced cholestatic liver injury.
    Addante A; Roncero C; Almalé L; Lazcanoiturburu N; García-Álvaro M; Fernández M; Sanz J; Hammad S; Nwosu ZC; Lee SJ; Fabregat I; Dooley S; Ten Dijke P; Herrera B; Sánchez A
    Liver Int; 2018 Sep; 38(9):1664-1675. PubMed ID: 29751359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protective effect of forsythiaside A on 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced cholestatic liver injury in mice: Based on targeted metabolomics and molecular biology technology.
    Fu K; Dai S; Li Y; Ma C; Xue X; Zhang S; Wang C; Zhou H; Zhang Y; Li Y
    Biochim Biophys Acta Mol Basis Dis; 2023 Dec; 1869(8):166822. PubMed ID: 37523877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.